Found: 16
Select item for more details and to access through your institution.
Acknowledgement to Referees.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 6, p. 693, doi. 10.1007/s11523-020-00777-z
- Publication type:
- Article
Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 6, p. 791, doi. 10.1007/s11523-020-00779-x
- By:
- Publication type:
- Article
Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
SB8: A Bevacizumab Biosimilar.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 6, p. 787, doi. 10.1007/s11523-020-00776-0
- By:
- Publication type:
- Article
Everolimus in Advanced Breast Cancer: A Systematic Review and Meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
A Melanoma-Tailored Next-Generation Sequencing Panel Coupled with a Comprehensive Analysis to Improve Routine Melanoma Genotyping.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Correction to: Biologic Drug Quality Assurance to Optimize HER2+ Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Rechallenge with Anti-EGFR Therapy in Metastatic Colorectal Cancer (mCRC): Results from South Australia mCRC Registry.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 6, p. 751, doi. 10.1007/s11523-020-00760-8
- By:
- Publication type:
- Article
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 6, p. 773, doi. 10.1007/s11523-020-00757-3
- By:
- Publication type:
- Article
Targeting Nuclear Export Proteins in Multiple Myeloma Therapy.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 6, p. 697, doi. 10.1007/s11523-020-00758-2
- By:
- Publication type:
- Article
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 6, p. 733, doi. 10.1007/s11523-020-00753-7
- By:
- Publication type:
- Article
Poly(ADP-Ribose) Polymerase Inhibitors in Prostate Cancer: Molecular Mechanisms, and Preclinical and Clinical Data.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 6, p. 709, doi. 10.1007/s11523-020-00756-4
- By:
- Publication type:
- Article
Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 6, p. 743, doi. 10.1007/s11523-020-00752-8
- By:
- Publication type:
- Article